John Burnett
Has grant
Associate Professor
United StatesResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
John Burnett is an Associate Professor at Sylvester Comprehensive Cancer Center in the United States. His research primarily focuses on HIV immunotherapy, gene editing technologies such as CRISPR/Cas9, and the development of preclinical models for studying HIV and associated diseases. Recent publications include investigations into engineered deletions of HIV, the synergy of arsenic trioxide and venetoclax in treating AML, and novel approaches to immune response enhancement against HIV.
Recent Grants
Grant: Close
CMV-specific T cells expressing anti-HIV CAR and CMV vaccine boost as immunotherapy for HIV/AIDS
Open Date: 2018-12-01
Close Date: 2022-12-31
Grant: Close
Transcriptional control, targeted modification, and excision of HIV in the brain
Open Date: 2017-04-14
Close Date: 2022-02-28
Grant: Close
Modulating Stochastic Gene Expression for Cell-fate Control and Therapeutics
Open Date: 2014-06-01
Close Date: 2026-02-28
Grant: Close
RNA-guided genome engineering for HIV resistance
Open Date: 2014-03-01
Close Date: 2016-02-29
Grant: Close
Expression of anti-HIV siRNA in Blood Cells
Open Date: 2003-07-01
Close Date: 2016-12-31
Articles (10)
Year:
2024
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Collaborators (5)
Kevin Morris
Professor
Griffith University
Xinyue Chen
Gladstone Institutes
Nathan Beutler
Scripps Research Institute
Tristan Scott
Assistant Research Professor
City of Hope
Ryan Urak
Assistant Research Professor
City Of Hope National Medical Center
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.